Hls Therapeutics Stock Probability of Future Pink Sheet Price Finishing Under 4.76
| HLTRF Stock | USD 2.40 0.04 1.64% |
HLS |
HLS Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HLS Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HLS Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| HLS Therapeutics had very high historical volatility over the last 90 days | |
| HLS Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 60.01 M. Net Loss for the year was (13.12 M) with profit before overhead, payroll, taxes, and interest of 50.36 M. | |
| About 64.0% of the company shares are owned by institutional investors |
HLS Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of HLS Pink Sheet often depends not only on the future outlook of the current and potential HLS Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HLS Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.5 M |
HLS Therapeutics Technical Analysis
HLS Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. HLS Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of HLS Therapeutics. In general, you should focus on analyzing HLS Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
HLS Therapeutics Predictive Forecast Models
HLS Therapeutics' time-series forecasting models is one of many HLS Therapeutics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary HLS Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about HLS Therapeutics
Checking the ongoing alerts about HLS Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HLS Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| HLS Therapeutics had very high historical volatility over the last 90 days | |
| HLS Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 60.01 M. Net Loss for the year was (13.12 M) with profit before overhead, payroll, taxes, and interest of 50.36 M. | |
| About 64.0% of the company shares are owned by institutional investors |
Other Information on Investing in HLS Pink Sheet
HLS Therapeutics financial ratios help investors to determine whether HLS Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.